Clinical Trials Logo

Renal Insufficiency clinical trials

View clinical trials related to Renal Insufficiency.

Filter by:

NCT ID: NCT03947346 Active, not recruiting - Clinical trials for Neuroblastoma Survivors

Biomarkers of Renal Dysfunction in Neuroblastoma Survivors

Start date: May 9, 2019
Phase:
Study type: Observational

The main purpose of this study is to learn more about biomarkers of kidney function in the blood and urine of neuroblastoma survivors. A biomarker is a biological molecule found in blood, urine, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition.

NCT ID: NCT03874117 Active, not recruiting - Hemodialysis Clinical Trials

Efficacy of Twice Weekly Hemodialysis in Patients With Residual Kidney Function

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

The study will determine the efficacy of twice weekly hemodialysis in patients with residual kidney function.

NCT ID: NCT03791580 Active, not recruiting - Clinical trials for Congestive Heart Failure

Reducing High-Risk Geriatric Polypharmacy Via EHR Nudges: Pilot Phase

Start date: February 11, 2019
Phase: N/A
Study type: Interventional

Polypharmacy is common among older adults in the United States and is associated with harms such as adverse drug reactions and higher costs of care. This pilot-phase project is designed to test two electronic health record (EHR)-based behavioral economic nudges to help primary care clinicians reduce the rate of high-risk polypharmacy among their older adult patients.

NCT ID: NCT03789708 Active, not recruiting - Clinical trials for Kidney Failure, Chronic

Effects of Gum Arabic Supplementation in Hemodialysis Patients

Start date: November 1, 2018
Phase: N/A
Study type: Interventional

Gum Arabic is a naturally produced gummy exudate from Acacia Senegal tree. It's a complex polysaccharide with proven prebiotic properties. Through its effect on intestinal bacteria, it's expected to reduce systemic levels of toxic bacterial metabolites and reduce inflammatory markers.By increasing fecal bacteria mass it's also expected to reduce blood urea level. These changes are potentially beneficial to hemodialysis patients who suffer from disturbed intestinal flora and a chronic inflammatory status. The investigators hypothesize that supplementing the diet of hemodialysis patients with Gum Arabic for four weeks would reduce inflammatory markers, increase total anti-oxidant capacity and reduce blood urea concentration.

NCT ID: NCT03767803 Active, not recruiting - Hypertension Clinical Trials

Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women

Start date: October 1, 2018
Phase:
Study type: Observational

Whole blood sample procurement study from pregnant women with signs and symptoms of Preeclampsia.

NCT ID: NCT03721952 Active, not recruiting - Clinical trials for Pulmonary Disease, Chronic Obstructive

Facilitating Communication Study

FCS2
Start date: April 17, 2019
Phase: N/A
Study type: Interventional

This study is a randomized clinical trial of an intervention to improve outcomes for patients and their family by using ICU nurse facilitators to support, model, and teach communication strategies that enable patients and their families to secure care in line with patients' goals of care over an illness trajectory, beginning in the ICU and continuing to care in the community.

NCT ID: NCT03675906 Active, not recruiting - Clinical trials for Acute Kidney Failure

The Relationship Between Hypoalbuminemia and Development of Acute Kidney Failure (AKI) According to KDIGO Criteria

Start date: September 12, 2018
Phase:
Study type: Observational

This study was designed to determine the association between preoperative and postoperative hypoalbuminemia and AKI in older age hip fracture surgeons, to determine which period of hypoalbuminemia contributes more to AKI development, the incidence of AKI according to anesthesia type, the presence of other factors affecting AKI development, the duration of hospitalization and cost- to be investigated.

NCT ID: NCT03672110 Active, not recruiting - Renal Failure Clinical Trials

Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen

S&L
Start date: September 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate non-inferiority of an advagraf based immunosuppressive regimen with slower dose tapering and lower starting dose of Advagraf compared with a standard Advagraf-based immunosuppressive regimen in de novo renal transplantation. Non inferiority will be assessed by a combined study endpoint consisting of the development of biopsy-proven rejection of BANFF class Ia or higher and/or graft loss and/or patient death within the first six months after renal transplantation.

NCT ID: NCT03645681 Active, not recruiting - Clinical trials for Kidney Failure, Chronic

Evaluating the Safety and Effectiveness of the InnAVasc Graft for Dialysis Access in Patients With Kidney Failure

Start date: January 2, 2019
Phase: N/A
Study type: Interventional

The CSP-1001 study will evaluate the safety and effectiveness of the InnAVasc arteriovenous graft (AVG) when implanted in and used for hemodialysis in participants suffering from end stage renal failure (ESRD). The InnAVasc AVG is implanted and used similar to other standard of care dialysis grafts currently on the market. However, the InnAVasc AVG has been uniquely designed to potentially allow for immediate needle access (same day as implant surgery as opposed to 2-4 weeks of waiting), to potentially reduce excessive bleeding from the graft after dialysis, and it may provide protection from improper or missed needle cannulation attempts.

NCT ID: NCT03436368 Active, not recruiting - Anesthesia Clinical Trials

Continuous Spinal Anesthesia in Renal Transplantation

Start date: February 20, 2018
Phase: N/A
Study type: Interventional

Renal transplantation is now recognized as a treatment of choice for patients with end-stage renal disease. An adequate anesthetic technique should achieve hemodynamic stability and enhance perfusion of the transplanted kidney. The aim of this study is to assess the use & effects of continuous spinal anesthesia for kidney transplantation recipients, compared with balanced general anesthesia.